You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Maria Gallo1, Gemma Navarro2,3, Rafael Franco4,5
1Department of Experimental and Health Sciences, Pompeu Fabra University, 08003 Barcelona, Spain. maria.gallo@upf.edu.
A novel cyclic peptide effectively disrupts G-protein-coupled receptor (GPCR) oligomerization by targeting transmembrane sequences. This cyclic peptide shows enhanced stability and efficacy compared to its linear form.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: